Source: http://health.yahoo.net/news/s/nm/arqule-daiichi-sankyo-stop-development-of-lung-cancer-drug
Tuesday, 2 October 2012
ArQule, Daiichi Sankyo stop development of lung cancer drug
(Reuters) - Biotechnology company ArQule Inc and Japan's Daiichi Sankyo Co Ltd said they will discontinue a late-stage trial of their experimental lung cancer drug after an interim analysis showed it would not meet the main goal of improving o...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: only a member of this blog may post a comment.